Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) Blockade

1 Nov 2019

Abstract excerpt

PURPOSE Response to programmed cell death protein 1 (PD-1) blockade is often conceptualized as resulting from reinvigoration of tumor-infiltrating lymphocytes. However, recruited antitumor immunity from the periphery may also be an important contributor to response. A detailed assessment of the response dynamics of individual metastasis could provide insight to the systemic and local features that mediate...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Immunotherapy and Biomarkers
Share to Immunotherapy and Immune Responses
Share to Melanoma and MAPK Pathways

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31675272
DOI: 10.1200/jco.19.00709

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Lesion-Level Response Dynamics to Programmed Cell Death Protein (PD-1) BlockadePMID 31675272Read ↗

Progression phenotypes to anti-PD-(L)1 therapy and subsequent management of patients with metastatic NSCLC: A real-world cohort study.Semantic proximity Read ↗

Mapping Intrapatient Response Heterogeneity and Lesion-specific Relapse Dynamics in Metastatic Colorectal CancerSemantic proximity Read ↗

Discordance of immunotherapy response predictive biomarkers between primary lesions and paired metastases in tumours: A systematic review and meta-analysis.Semantic proximity Read ↗

Spatiotemporal Heterogeneity across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer.Semantic proximity Read ↗

Patterns of progression in patients with synchronous oligometastatic non-small cell lung cancer after systemic and local radical treatment.Semantic proximity Read ↗

Clinical significance of heterogeneity in response to retreatment with epidermal growth factor receptor tyrosine kinase inhibitors in patients with lung cancer acquiring secondary resistance to the drug.Semantic proximity Read ↗

Understanding metastasis mixed-treatment responses through genomic analysesSemantic proximity Read ↗

Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer.Semantic proximity Read ↗

A Pan-Cancer Analysis of Lesion-Level Treatment Response to Extend the ‘Seed and Soil’ ParadigmSemantic proximity Read ↗

Timing in combination with radiotherapy and patterns of disease progression in non-small cell lung cancer treated with EGFR-TKI.Semantic proximity Read ↗

Heterogeneous response and progression patterns reveal phenotypic heterogeneity of tyrosine kinase inhibitor response in metastatic renal cell carcinomaSemantic proximity Read ↗

Spatial intratumor heterogeneity of programmed death-ligand 1 expression predicts poor prognosis in resected non–small cell lung cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.